English
Back
Download
Log in to access Online Inquiry
Back to the Top

Update

$Nuvation Bio (NUVB.US)$ Reuters· just1min
U.S. Food and Drug Administration Accepts for Priority Review Nuvation Bio’s New Drug Application for Taletrectinib for the Treatment of Advanced Ros1-Positive Non-Small Cell Lung Cancer! June 23, 2025
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
3382 Views
Comment
Sign in to post a comment
    5169
    Followers
    23
    Following
    74K
    Visitors
    Follow
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.